Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 160 articles:
HTML format



Single Articles


    December 2022
  1. YEOH BS, Saha P, Golonka RM, Zou J, et al
    Enterohepatic Shunt-Driven Cholemia Predisposes to Liver Cancer.
    Gastroenterology. 2022;163:1658-1671.
    PubMed     Abstract available


  2. ZHU Y, Shi H, He S
    An Unusual Cause of Gastric Variceal Bleeding.
    Gastroenterology. 2022;163:1502-1504.
    PubMed    


  3. ROBBINS J, El Hassan I, Siebenburgen C
    Evaluation and Treatment of GI Bleeding in a 51-Year-Old Man.
    Gastroenterology. 2022;163:1498-1501.
    PubMed    


    November 2022
  4. OH AR, Jeong Y, Yu J, Minh Tam DT, et al
    Hepatocyte Kctd17 inhibition ameliorates glucose intolerance and hepatic steatosis caused by obesity-induced Chrebp stabilization.
    Gastroenterology. 2022 Nov 16:S0016-5085(22)01295.
    PubMed     Abstract available


  5. ZHANG H, Peng Y, Tang X
    Comments on "Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand".
    Gastroenterology. 2022 Nov 14. pii: S0016-5085(22)01271.
    PubMed    


  6. WANG Z, Tai Y, Wu H
    A rare cause of abdominal pain after transjugular intrahepatic portosystemic shunt.
    Gastroenterology. 2022 Nov 10. pii: S0016-5085(22)01258.
    PubMed    


  7. BRANDI G, Tovoli F, Tavolari S
    Have We Found the "Holy Grail" That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?
    Gastroenterology. 2022 Nov 4. pii: S0016-5085(22)01252.
    PubMed    


  8. PRASOPPOKAKORN T, Rerknimitr R
    An Unusual Complication of Endoscopic Cyanoacrylate Injection for Gastric Varix.
    Gastroenterology. 2022;163:1186-1187.
    PubMed    


  9. MAGAHIS P, Rosenblatt R, Mahadev S
    An Unusual Cause of Right Upper Quadrant Pain With Abnormal Liver Enzymes.
    Gastroenterology. 2022;163:e3-e5.
    PubMed    


    October 2022
  10. RAHAL HK, Tabibian JH, Issaka RB, Quezada S, et al
    Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand.
    Gastroenterology. 2022 Oct 7. pii: S0016-5085(22)00721.
    PubMed     Abstract available


  11. BEHARI J
    Needle-free Nonalcoholic Fatty Liver Disease Prognostication: Moving One Step Closer.
    Gastroenterology. 2022;163:819-822.
    PubMed    


  12. AJMERA V, Kim BK, Yang K, Majzoub AM, et al
    Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
    Gastroenterology. 2022;163:1079-1089.
    PubMed     Abstract available


  13. SHINGINA A, Sarkar M, Feld L
    On the Importance of Safe Access to Reproductive Options for Adolescents and Women With Liver Disease.
    Gastroenterology. 2022;163:792-794.
    PubMed    


  14. BAJAJ JS, Nagy LE
    Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care.
    Gastroenterology. 2022;163:840-851.
    PubMed     Abstract available


    September 2022
  15. LI H, Zheng J, Xu Q, Yang Y, et al
    Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation.
    Gastroenterology. 2022 Sep 28. pii: S0016-5085(22)01085.
    PubMed     Abstract available


  16. DARA L
    No Necroptosis in Hepatocytes: The Final Nail in the Coffin?
    Gastroenterology. 2022 Sep 22. pii: S0016-5085(22)01083.
    PubMed    


  17. MURILLO PEREZ CF, Fisher H, Hiu S, Kareithi D, et al
    Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
    Gastroenterology. 2022 Sep 13. pii: S0016-5085(22)01060.
    PubMed     Abstract available


  18. HABER PK, Castet F, Torres-Martin M, Andreu-Oller C, et al
    Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.
    Gastroenterology. 2022 Sep 12. pii: S0016-5085(22)01039.
    PubMed     Abstract available


  19. LONG MT, Noureddin M, Lim JK
    AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
    Gastroenterology. 2022;163:764-774.
    PubMed     Abstract available


  20. LEE BP, Terrault NA
    Advocacy for Equity in Transplantation Access for Alcohol-Associated Liver Disease: How Research Changed Medi-Cal Policy.
    Gastroenterology. 2022;163:539-542.
    PubMed    


    August 2022
  21. PRESTON SP, Stutz MD, Allison CC, Nachbur U, et al
    Epigenetic silencing of RIPK3 in hepatocytes prevents MLKL-mediated necroptosis from contributing to liver pathologies.
    Gastroenterology. 2022 Aug 26. pii: S0016-5085(22)01021.
    PubMed     Abstract available


  22. LIU J, Feng G
    A 41-year-old man with an abdominal mass and hepatomegaly.
    Gastroenterology. 2022 Aug 17. pii: S0016-5085(22)00957.
    PubMed    


  23. D'ALESSIO A, Pinato DJ
    Dissecting the tumour microenvironment to predict immunotherapy response in hepatocellular cancer.
    Gastroenterology. 2022 Aug 11. pii: S0016-5085(22)00950.
    PubMed    


  24. DEBOSCH B
    Targeting de novo lipogenesis by different approaches shows promise in non-alcoholic steatohepatitis.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00915.
    PubMed    


  25. CLIFFORD C, Ryan R, Houlihan D
    An interesting case of hepatomegaly.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00945.
    PubMed    


  26. LO GH
    The beauty and sorrow of using PPI in patients with cirrhosis.
    Gastroenterology. 2022 Aug 3. pii: S0016-5085(22)00892.
    PubMed    


  27. MULLISH BH
    Further Insights Into the Impact of Bariatric Surgery on the Progression of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2022;163:528-529.
    PubMed    


  28. LE COSQUER G, Brunac AC, Peron JM
    An Unusual Case of Budd-Chiari Syndrome: Diagnosis and Treatment.
    Gastroenterology. 2022;163:e4-e5.
    PubMed    


    July 2022
  29. BENHAMMOU JN, Rich NE, Cholankeril G, Zhang P, et al
    DETECT: Development of Technologies for Early HCC Detection.
    Gastroenterology. 2022;163:21-27.
    PubMed    


  30. JAN J, Osho A, Murphy CC, Mazure CM, et al
    Gender, Age, Racial and Ethnic Disparities in Clinical Trial Enrollment for Primary Liver Cancer.
    Gastroenterology. 2022;163:14-20.
    PubMed    


  31. TERRAULT NA, Williamson C
    Pregnancy-Associated Liver Diseases.
    Gastroenterology. 2022;163:97-117.
    PubMed     Abstract available


  32. KARACHALIOU GS, Shi C, Abdelmalek MF
    Liver Mass: Thinking Out of the Box.
    Gastroenterology. 2022;163:e10-e12.
    PubMed    


    June 2022
  33. KIM NJ, Vutien P, Berry K, Ioannou GN, et al
    Hepatocellular carcinoma risk declines but remains high enough for screening in the first 7 years after HCV cure with DAAs in patients with cirrhosis or high FIB-4.
    Gastroenterology. 2022 Jun 28. pii: S0016-5085(22)00681.
    PubMed    


  34. BLAIR AB, Wang J, Davelaar J, Baker A, et al
    Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy.
    Gastroenterology. 2022 Jun 16. pii: S0016-5085(22)00645.
    PubMed     Abstract available


  35. YING X, Rosenblatt R, Fortune BE
    Trends in Industry Payments to Gastroenterologists and Hepatologists in the United States from 2014 to 2020.
    Gastroenterology. 2022 Jun 14. pii: S0016-5085(22)00647.
    PubMed    


  36. DUURSMA SS, Verkade HJ, Bodewes FAJA
    Cirrhosis and portal hypertension in compound heterozygous people with CF harboring one F508del CFTR gene mutation.
    Gastroenterology. 2022 Jun 10. pii: S0016-5085(22)00624.
    PubMed    


  37. BAUER KC, Littlejohn PT, Ayala V, Creus-Cuadros A, et al
    Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective.
    Gastroenterology. 2022;162:1858-1875.
    PubMed     Abstract available


  38. SULLIVAN S, Jirapinyo P, Kumbhari V
    Clinical Care Pathway for the Risk Stratification and Management of Patients With Non-alcoholic Fatty Liver Disease.
    Gastroenterology. 2022;162:2131-2132.
    PubMed    


    May 2022
  39. WANG J, Liu D, Chen S
    Proton Pump Inhibitors for Patients with Cirrhosis: Good Medicine or Poison?
    Gastroenterology. 2022 May 17. pii: S0016-5085(22)00514.
    PubMed    


  40. NATSUI K, Maruyama M, Terai S
    Intrahepatic bile duct foreign body with cholangitis after pylorus preserving pancreatoduodenectomy: Is it a fish bone?
    Gastroenterology. 2022 May 14. pii: S0016-5085(22)00507.
    PubMed    


  41. HU S, Molina L, Tao J, Liu S, et al
    NOTCH-YAP1/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma.
    Gastroenterology. 2022 May 9. pii: S0016-5085(22)00477.
    PubMed     Abstract available


  42. SINGH SP
    Proton pump inhibitor increasing the risk of infection and mortality in cirrhosis- need closer look!
    Gastroenterology. 2022 May 2. pii: S0016-5085(22)00458.
    PubMed    


  43. DONNELLY MC, Stableforth W, Krag A, Reuben A, et al
    The Negative Bidirectional Interaction Between Climate Change and the Prevalence and Care of Liver Disease: A Joint BSG, BASL, EASL, and AASLD Commentary.
    Gastroenterology. 2022;162:1561-1567.
    PubMed    


  44. GOUDSMIT BFJ, Putter H, Van Hoek B
    The Model for End-Stage Liver Disease 3.0: An Update Without Proven Accuracy.
    Gastroenterology. 2022;162:1781-1782.
    PubMed    


  45. GAN W, Liao B, Li X
    A Rare Cause of Liver Fibrosis in Adulthood.
    Gastroenterology. 2022;162:e1-e3.
    PubMed    


    April 2022
  46. CACCIOLA I
    Effects of PPIs in cirrhotic patients: What do we really know?
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00452.
    PubMed    


  47. COPPS KD, Tao R
    A role for hepatic insulin signaling in alpha1-antitrypsin deficiency.
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00457.
    PubMed    


  48. MAHMUD N, Serper M, Taddei TH, Kaplan DE, et al
    The Association between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients with Cirrhosis: A Veterans Affairs Cohort Study.
    Gastroenterology. 2022 Apr 6. pii: S0016-5085(22)00352.
    PubMed     Abstract available


  49. YANG Y, Ju C
    Sulfation in Acetaminophen-Induced Liver Injury: Friend or Foe?
    Gastroenterology. 2022;162:1035-1037.
    PubMed    


  50. XU P, Xi Y, Wang P, Luka Z, et al
    Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure.
    Gastroenterology. 2022;162:1226-1241.
    PubMed     Abstract available


  51. QIAN T, Fujiwara N, Koneru B, Ono A, et al
    Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.
    Gastroenterology. 2022;162:1210-1225.
    PubMed     Abstract available


    March 2022
  52. RUDNICK DA, Huang J, Hidvegi T, Chu AS, et al
    Regulation of PGC1alpha downstream of the insulin signaling pathway plays a role in the hepatic proteotoxicity of mutant alpha1-antitrypsin deficiency variant Z.
    Gastroenterology. 2022 Mar 14. pii: S0016-5085(22)00261.
    PubMed     Abstract available


  53. VELENOSI TJ, Ben-Yakov G, Podszun MC, Hercun J, et al
    Postprandial plasma lipidomics reveal specific alteration of hepatic-derived diacylglycerols in non-alcoholic fatty liver disease.
    Gastroenterology. 2022 Mar 10. pii: S0016-5085(22)00235.
    PubMed     Abstract available


  54. ALTAYAR O, Shah R, Chang CY, Falck-Ytter Y, et al
    AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma.
    Gastroenterology. 2022;162:937-951.
    PubMed    


  55. SU GL, Altayar O, O'Shea R, Shah R, et al
    AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.
    Gastroenterology. 2022;162:920-934.
    PubMed     Abstract available


  56. MAYDEO A, Patil G
    How to Approach a Patient With Gastric Varices.
    Gastroenterology. 2022;162:689-695.
    PubMed    


    February 2022
  57. CHENG N, Ren Y, Zhou J, Zhang Y, et al
    Deep learning-based classification of hepatocellular nodular lesions on whole-slide histopathologic images.
    Gastroenterology. 2022 Feb 21. pii: S0016-5085(22)00155.
    PubMed     Abstract available


  58. CARRIQUE L, Lynch J, Selzner N
    We thank Bekki et al and Bhagat et al for their comments on our article "Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse". Bekki et al pointed out a trend toward inferior graft su
    Gastroenterology. 2022 Feb 3. pii: S0016-5085(22)00103.
    PubMed    


  59. STRAZZABOSCO M, Cabibbo G, Colombo M
    Adjusting BCLC staging system to the evolving landscape of Hepatocellular Carcinoma. A look to the future.
    Gastroenterology. 2022 Feb 2. pii: S0016-5085(22)00090.
    PubMed    


  60. KANNEGANTI M, Singal AG
    INCIDENCE OF HEPATOCELLULAR CARCINOMA IN NONALCOHOLIC FATTY LIVER DISEASE.
    Gastroenterology. 2022 Feb 1. pii: S0016-5085(22)00092.
    PubMed     Abstract available


  61. LEE SK, Wong JC, Ng JJ
    An Uncommon Cause of Hematemesis in a Patient With End-stage Renal Disease.
    Gastroenterology. 2022;162:404-405.
    PubMed    


  62. TAI Y, Wang Z, Wu H
    An Unusual Cause of Isolated Gastric Varices.
    Gastroenterology. 2022;162:e4-e6.
    PubMed    


  63. QU C, Wang HY, Xiu DR
    A Rare Liver Tumor Nodule.
    Gastroenterology. 2022;162:e1-e3.
    PubMed    


    January 2022
  64. WILLIAMS R, White PM, Balzora S
    "A T.E.A.M. Approach to Diversity, Equity and Inclusion in Gastroenterology and Hepatology".
    Gastroenterology. 2022 Jan 21. pii: S0016-5085(22)00035.
    PubMed    


  65. WILSON SR, Duncan AW
    Single-Cell DNA Sequencing Reveals Chromosomal Diversity in HCC and a Novel Model of HCC Evolution.
    Gastroenterology. 2022;162:46-48.
    PubMed    


    December 2021
  66. YANG AH, Gandhi S, Urrunaga NH
    Liver Tumor post Liver Transplantation for Hepatitis C Cirrhosis: An Unusual Cause.
    Gastroenterology. 2021 Dec 26. pii: S0016-5085(21)04161.
    PubMed    


  67. FORNER A, Colombo M
    The maze of systemic therapy for hepatocellular carcinoma: did we find the compass?
    Gastroenterology. 2021 Dec 23. pii: S0016-5085(21)04121.
    PubMed    


  68. KEFALAKES H
    DISPARITIES IN CIRRHOSIS MANAGEMENT OF BLACK PATIENTS: DO WE KNOW WHAT TO ADDRESS?
    Gastroenterology. 2021 Dec 1. pii: S0016-5085(21)03811.
    PubMed    


  69. GERMAN MN, Brown R, Lucey MR
    Out With the Old, in With the New: Replacing the "6-Month Abstinence Rule" With Integrated Care for Alcohol-Associated Liver Disease.
    Gastroenterology. 2021;161:1795-1797.
    PubMed    


  70. POLLO-FLORES P, Trebicka J
    Statins After Variceal Bleeding Are Beneficial, but Still an Unexplained Mystery?
    Gastroenterology. 2021;161:2067-2068.
    PubMed    


  71. BARRITT AS 4TH, Moon AM
    Bariatric Surgery and Cancer Risk in Nonalcoholic Fatty Liver Disease-Effective Intervention for a Select Few.
    Gastroenterology. 2021;161:2063-2064.
    PubMed    


  72. RAMAI D, Facciorusso A
    Liver Cancer Reduction After Bariatric Surgery: Time to Expand Its Indication?
    Gastroenterology. 2021;161:2063.
    PubMed    


  73. KIM WR, Mannalithara A, Heimbach JK, Kamath PS, et al
    MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Gastroenterology. 2021;161:1887-1895.
    PubMed     Abstract available


  74. SACK JS, Patel RS, Ahmad J
    Nausea and Vomiting 8 Months After Liver Transplantation.
    Gastroenterology. 2021;161:e12-e14.
    PubMed    


    November 2021
  75. LOOMBA R, Ratziu V, Harrison SA
    Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2021 Nov 22. pii: S0016-5085(21)03795.
    PubMed    


  76. BHAGAT N, Rathi S, Singh V
    Early Transplantation for Alcohol-Related Cirrhosis: Risks, Resources, and Relapse.
    Gastroenterology. 2021 Nov 5. pii: S0016-5085(21)03724.
    PubMed    


  77. KANWAL F, Shubrook JH, Adams LA, Pfotenhauer K, et al
    Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2021;161:1657-1669.
    PubMed     Abstract available


  78. WANG X, Cheng Z
    Nodules on the Lower Legs With Ankle Joint Pain.
    Gastroenterology. 2021;161:1390-1392.
    PubMed    


  79. VARGAS JF, Arab JP
    Pulsatile Epigastric Mass and Liver Masses in a 38-Year-Old Patient With Splenomegaly Since Childhood.
    Gastroenterology. 2021;161:e14-e16.
    PubMed    


    October 2021
  80. LEE TH, Roper J, King L
    MIRROR MIRROR ON THE WALL, WHO IS THE FITTEST OF THEM ALL: A NOVEL PREDICTION MODEL FOR POSTOPERATIVE HEPATIC DECOMPENSATION IN PATIENTS WITH CIRRHOSIS.
    Gastroenterology. 2021 Oct 21. pii: S0016-5085(21)03662.
    PubMed     Abstract available


  81. LIU N, Chang CW, Steer CJ, Wang XW, et al
    MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication between Kupffer Cells and Tregs.
    Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03652.
    PubMed     Abstract available


  82. PEERY AF, Crockett SD, Murphy CC, Jensen ET, et al
    Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021.
    Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03655.
    PubMed     Abstract available


  83. LOUISSAINT J, Gibbs JT, Lok AS, Tapper EB, et al
    Strategies to Improve Video Visit Use in Persons With Liver Disease.
    Gastroenterology. 2021;161:1080-1084.
    PubMed    


    September 2021
  84. INTAGLIATA NM, Davitkov P, Allen AM, Falck-Ytter YT, et al
    AGA Technical Review on Coagulation in Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03477.
    PubMed    


  85. O'SHEA RS, Davitkov P, Ko CW, Rajasekhar A, et al
    AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03382.
    PubMed    


  86. DREYER SB, Upstill-Goddard R, Legrini A, Biankin AV, et al
    Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence.
    Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03522.
    PubMed    


  87. BEKKI Y, Fenig Y
    Evaluation of Early Liver Transplantation for Alcohol-Related Cirrhosis.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03491.
    PubMed    


  88. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide for Programs, Faculty, and Fellows.
    Gastroenterology. 2021 Sep 3. pii: S0016-5085(21)03335.
    PubMed    


  89. GUO L, Yi X, Chen L, Zhang T, et al
    Single cell DNA sequencing reveals punctuated and gradual clonal evolution in hepatocellular carcinoma.
    Gastroenterology. 2021 Sep 2. pii: S0016-5085(21)03471.
    PubMed     Abstract available


  90. KANWAL F, Shubrook JH, Younossi Z, Natarajan Y, et al
    Preparing for the NASH Epidemic: A Call to Action.
    Gastroenterology. 2021;161:1030-1042.
    PubMed     Abstract available


  91. HABER PK, Puigvehi M, Castet F, Lourdusamy V, et al
    Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).
    Gastroenterology. 2021;161:879-898.
    PubMed     Abstract available


  92. DE BUCOURT M
    A Visual Engram Worth Remembering.
    Gastroenterology. 2021;161:809-810.
    PubMed    


  93. FUCHS A, Samovski D, Smith GI, Cifarelli V, et al
    Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2021;161:968-981.
    PubMed     Abstract available


    August 2021
  94. BALZORA S, May FP, Ogedegbe G
    COVID-19 and Social Determinants of Health in Gastroenterology and Hepatology.
    Gastroenterology. 2021 Aug 26. pii: S0016-5085(21)03438.
    PubMed    


  95. SU F
    COVID-19 and cirrhosis: a combination we must strive to prevent.
    Gastroenterology. 2021 Aug 25. pii: S0016-5085(21)03417.
    PubMed    


  96. AZZIMATO V, Chen P, Barreby E, Morgantini C, et al
    Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity.
    Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03410.
    PubMed     Abstract available


  97. OLYNYK JK, Ramm GA
    RISK OF LIVER CANCER IN HFE-HEMOCHROMATOSIS.
    Gastroenterology. 2021 Aug 19. pii: S0016-5085(21)03405.
    PubMed     Abstract available


  98. TAI CS, Ni YH, Lee PI
    An Unusual Case with a Huge Hepatic Cystic Mass.
    Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03357.
    PubMed    


  99. CARRIQUE L, Quance J, Tan A, Abbey S, et al
    Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse.
    Gastroenterology. 2021 Aug 6. pii: S0016-5085(21)03342.
    PubMed     Abstract available


  100. GOUGH NR, Xiang X, Mishra L
    TGF-beta Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer.
    Gastroenterology. 2021;161:434-452.
    PubMed     Abstract available


    July 2021
  101. MEHTA N, Frenette C, Tabrizian P, Hoteit M, et al
    Down-staging Outcomes for Hepatocellular Carcinoma: Results from the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
    Gastroenterology. 2021 Jul 28. pii: S0016-5085(21)03284.
    PubMed     Abstract available


  102. LOOMBA R, Mohseni R, Lucas KJ, Gutierrez JA, et al
    TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial.
    Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03276.
    PubMed     Abstract available


  103. GE J, Pletcher MJ, Lai JC
    Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study.
    Gastroenterology. 2021 Jul 17. pii: S0016-5085(21)03244.
    PubMed     Abstract available


  104. YE P, Miao H, Chen Y
    An unusual case of symptomatic portal hypertension.
    Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03253.
    PubMed    


  105. MAAN R, Darwish Murad S, van der Meer AJ
    Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;161:371-372.
    PubMed    


  106. LI L, Liu C, Qi X
    Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;161:370-371.
    PubMed    


  107. PARIKH ND, Chung GS, Mellinger J, Blanchette JG, et al
    Alcohol Policies and Alcohol-related Liver Disease Mortality.
    Gastroenterology. 2021;161:350-352.
    PubMed    


  108. RUSTGI VK, Li Y, Gupta K, Minacapelli CD, et al
    Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity.
    Gastroenterology. 2021;161:171-184.
    PubMed     Abstract available


  109. SURAPANENI PK, Mills K, Renelus BD
    A Rare Complication of Sickle Cell Anemia.
    Gastroenterology. 2021;161:45-46.
    PubMed    


    June 2021
  110. CHIANG HC, Chien SC, Lin YJ
    Pleural effusion with gastric ulcer.
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03176.
    PubMed    


  111. TSOI AH, Garg M, Tsoi EH
    Peptic ulcer disease: an unusual presentation of a common problem.
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03174.
    PubMed    


  112. VALENTI L, Mondelli M, Colombo M
    Liver field during immunotherapy of hepatocellular carcinoma: some like it hot.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03165.
    PubMed    


  113. LI H, Liu H
    Recurrent Epistaxis and Diffuse Hepatic and Splenic Vascular Malformations.
    Gastroenterology. 2021 Jun 8. pii: S0016-5085(21)03091.
    PubMed    


  114. MEDICI V
    Expanding the Diagnostic Toolkit of Wilson Disease with ATP7B Peptides.
    Gastroenterology. 2021;160:2249-2251.
    PubMed    


  115. SU P, Hong J, Li T
    An Uncommon Lesion of the Liver.
    Gastroenterology. 2021;160:2258-2260.
    PubMed    


  116. COLLINS CJ, Yi F, Dayuha R, Duong P, et al
    Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease.
    Gastroenterology. 2021;160:2367-2382.
    PubMed     Abstract available


    May 2021
  117. EDWARDS LA, Goldenberg SD, Shawcross DL
    Meeting the challenge of antimicrobial resistance in cirrhosis: the invisible threat that lies within.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03065.
    PubMed    


  118. GARCIA-TSAO G, Abraldes JG
    Non-selective beta-blockers in compensated cirrhosis: Preventing variceal hemorrhage or preventing decompensation?
    Gastroenterology. 2021 May 11. pii: S0016-5085(21)02972.
    PubMed    


  119. PERRY IE, Azam MU, Yap JE
    Carcinoma Camouflage.
    Gastroenterology. 2021;160:1940-1942.
    PubMed    


  120. SHEN C, Zong Z, Xu N
    "Malignant" Liver Cysts Cause Liver Failure and Recurrence.
    Gastroenterology. 2021;160:e7-e9.
    PubMed    


  121. NAYAK LJ, Sondhi AR, Westerhoff M
    History!
    Gastroenterology. 2021;160:e5-e6.
    PubMed    


  122. HA NB, Wang CW, El-Nachef N
    An Unusual Mechanical Cause of Upper Gastrointestinal Hemorrhage.
    Gastroenterology. 2021;160:e1-e4.
    PubMed    


    April 2021
  123. PACK M
    Model Organisms Help Define the ABCs of Neonatal Cholestasis.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00636.
    PubMed    


  124. SHAMSADDINI A, Gillevet PM, Acharya C, Fagan A, et al
    Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients with Cirrhosis.
    Gastroenterology. 2021 Apr 12. pii: S0016-5085(21)00634.
    PubMed     Abstract available


  125. SHEEHAN JL, Brandler J, Rice MD
    A Case of Recurrent Hepatic Abscesses.
    Gastroenterology. 2021 Apr 8. pii: S0016-5085(21)00627.
    PubMed    


  126. PONZIANI FR, Nesci A, Del Zompo F, Santopaolo F, et al
    Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection.
    Gastroenterology. 2021;160:1891-1893.
    PubMed    


  127. KHAN MU, Mushtaq K, Alkaabi SR
    Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease.
    Gastroenterology. 2021;160:1894-1895.
    PubMed    


  128. VERMA N, Duseja A, Singh V
    Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease.
    Gastroenterology. 2021;160:1893-1894.
    PubMed    


  129. LUUKKONEN PK, Salomaa V, Aberg F
    The Pi *MZ Allele in Alpha-1 Antitrypsin Increases Liver-Related Outcomes in a Population-Based Study.
    Gastroenterology. 2021;160:1874-1875.
    PubMed    


  130. JAMIALAHMADI O, Mancina RM, Ciociola E, Tavaglione F, et al
    Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
    Gastroenterology. 2021;160:1634-1646.
    PubMed     Abstract available


    March 2021
  131. ASSELTA R, Paraboschi EM, Gerussi A, Cordell HJ, et al
    X chromosome contribution to the genetic architecture of primary biliary cholangitis.
    Gastroenterology. 2021 Mar 3. pii: S0016-5085(21)00466.
    PubMed     Abstract available


  132. CASADEI-GARDINI A, Cascinu S, Colombo M
    Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?
    Gastroenterology. 2021;160:1423-1424.
    PubMed    


  133. GOLDBERG D, Ross-Driscoll K, Lynch R
    County Differences in Liver Mortality in the United States: Impact of Sociodemographics, Disease Risk Factors, and Access to Care.
    Gastroenterology. 2021;160:1140-1150.
    PubMed     Abstract available


  134. KOBAYASHI H, Gieniec KA, Wright JA, Wang T, et al
    The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
    Gastroenterology. 2021;160:1224-1239.
    PubMed     Abstract available


  135. PRZYBYSZEWSKI EM, Deshpande V, Uchida AM
    An Unsuspected Cause of Rectal Bleeding.
    Gastroenterology. 2021;160:e1-e2.
    PubMed    


    February 2021
  136. YOUNOSSI ZM, Corey KE, Lim JK
    AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2021;160:912-918.
    PubMed     Abstract available


  137. SHINOZAWA T, Kimura M, Cai Y, Saiki N, et al
    High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.
    Gastroenterology. 2021;160:831-846.
    PubMed     Abstract available


  138. NASSANI N, Melitas C, Villa E
    An Unusual Cause of Watery Diarrhea.
    Gastroenterology. 2021;160:671-674.
    PubMed    


    January 2021
  139. ACHARYA C, Bajaj JS
    Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.
    Gastroenterology. 2021;160:556-572.
    PubMed     Abstract available


  140. NICOARA-FARCAU O, Han G, Rudler M, Angrisani D, et al
    Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;160:193-205.
    PubMed     Abstract available


    December 2020
  141. VAN DIJK M, Weehuizen TAF, Lowenberg M
    A rare cause of acute abdominal pain after endoscopic retrograde cholangiopancreaticography.
    Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35559.
    PubMed    


  142. ARVIND A, Osganian SA, Sjoquist JA, Corey KE, et al
    Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.
    Gastroenterology. 2020;159:2232-2234.
    PubMed    


    November 2020
  143. NOUREDDIN M, Jones C, Alkhouri N, Gomez EV, et al
    Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.
    Gastroenterology. 2020;159:1985-1987.
    PubMed    


  144. XANTHAKOS SA, Lavine JE, Yates KP, Schwimmer JB, et al
    Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
    Gastroenterology. 2020;159:1731-1751.
    PubMed     Abstract available


  145. LANG S, Demir M, Martin A, Jiang L, et al
    Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2020;159:1839-1852.
    PubMed     Abstract available


    October 2020
  146. VERBOVEN E, Moya IM, Sansores-Garcia L, Xie J, et al
    Regeneration Defects in Yap and Taz Mutant Mouse Livers are Caused by Bile Duct Disruption and Cholestasis.
    Gastroenterology. 2020 Oct 27. pii: S0016-5085(20)35324.
    PubMed     Abstract available


  147. DOUGAN M, Wang Y, Rubio-Tapia A, Lim JK, et al
    AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor (ICI) Colitis and Hepatitis: Expert Review.
    Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35282.
    PubMed     Abstract available


  148. ASEEM SO, Jalan-Sakrikar N, Chi C, Navarro-Corcuera A, et al
    Epigenomic Evaluation of Cholangiocyte TGFbeta Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35245.
    PubMed     Abstract available


  149. DE VRIES E, Bolier R, Goet J, Pares A, et al
    Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial.
    Gastroenterology. 2020 Oct 5. pii: S0016-5085(20)35226.
    PubMed     Abstract available


  150. ROMEO S
    MARC1 and HNRNPUL1: Two Novel Players in Alcohol-related Liver Disease.
    Gastroenterology. 2020;159:1231-1232.
    PubMed    


  151. RAMLI MNB, Lim YS, Koe CT, Demircioglu D, et al
    Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease.
    Gastroenterology. 2020;159:1471-1486.
    PubMed     Abstract available


    September 2020
  152. VILAR-GOMEZ E, Sookoian S, Pirola CJ, Liang T, et al
    ADH1B *2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
    Gastroenterology. 2020;159:929-943.
    PubMed     Abstract available


  153. CHAI C, Cox B, Yaish D, Gross D, et al
    Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Gastroenterology. 2020;159:999-1014.
    PubMed     Abstract available


  154. WANG Y, Pan Y, Zhou Z
    An Unusual Cause of Fever in a Man With a Liver Mass.
    Gastroenterology. 2020;159:842-844.
    PubMed    


    August 2020
  155. JANSSON-KNODELL CL, Walker MJ, Fischer M
    Pancytopenia in a Young Male Patient with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Aug 7. pii: S0016-5085(20)35027.
    PubMed    


  156. NABI O, Lacombe K, Boursier J, Mathurin P, et al
    Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.
    Gastroenterology. 2020;159:791-793.
    PubMed    


  157. SCHNEIDER CV, Hamesch K, Gross A, Mandorfer M, et al
    Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi *Z Variant of AAT (Pi *MZ vs Pi *ZZ genotype) and Noncarriers.
    Gastroenterology. 2020;159:534-548.
    PubMed     Abstract available


  158. GUPTA V, Gupta I, Park J, Bram Y, et al
    Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.
    Gastroenterology. 2020;159:624-638.
    PubMed     Abstract available


  159. NAUDIN CR, Maner-Smith K, Owens JA, Wynn GM, et al
    Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.
    Gastroenterology. 2020;159:639-651.
    PubMed     Abstract available


    June 2020
  160. RUETHER DF, Menz A, Manthey CF
    A Dishevelled Man with Inflammatory Bowel Disease and Signs of Infection.
    Gastroenterology. 2020 Jun 5. pii: S0016-5085(20)34749.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: